lisocabtagene maraleucel
bms
['leusm', 'lymsm', 'nhl 001', 'transcend,nhl,001', 'nhl', 'liso-cel']
congress #17icml| late-breaking abstract
michael l wang presented transcend nhl 001 study of liso-cel in patients with r/r nhl. n=88, orr=83.1, cr=72.3. liso-cel was well tolerated with low rates of grade 3 crs, neurological events &amp; infections #lymsm #leusm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm